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Abstract
Background: The burden of mother-to-child transmission of HIV in Uganda is high. The aim of this paper is to
describe the experience of the first 7 years of the prevention of mother- to- child transmission of HIV (PMTCT)
programme in Mbale Regional Hospital, Eastern Uganda, with particular reference to the lessons learnt in changing
from voluntary counselling and testing (VCT) to routine counselling and testing (RCT) for HIV testing in antenatal
services.
Methods: The study was a retrospective analysis of the PMTCT records of Mbale Regional Referral Hospital,
Uganda, from May 2002 to April 2009. The data on HIV testing of pregnant women and their male partners was
extracted from the reports and registers using a standardized data extraction form, and data was analysed using
descriptive statistics. Permission to conduct the study was obtained from School of Medicine, Makerere University
College of Health Sciences; Uganda National Council of Science and Technology, and Mbale Hospital.
Results: A total of 54 429 new antenatal (ANC) attendees and 469 male-partners accessed antenatal services at
Mbale Regional Referral Hospital. There was a sustained, significant increase in HIV testing among new ANC
attendees from 22% during the VCT period to 88% during the RCT period (p = 0.002), while among male partners,
HIV testing increased from 88% to 100% (p = 0.010) However, the overall number of male partners who tested for
HIV remained very low despite the change from VCT to RCT approach in HIV testing.
Conclusions: Routine offer of antenatal HIV testing dramatically increased HIV testing in pregnant women and
their partners in Uganda. Our findings call for further strengthening of the policy for routine HIV testing in
antenatal clinics. Our study also showed that male partner HIV testing in antenatal clinics is low and this area
needs further work through research and innovative interventions in order to improve male partner involvement.
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\Background
Over the last decade, large efforts have been used to
prevent mother-to-child transmission (MTCT) of HIV
in Sub-Saharan Africa. The prevention of mother-to-
child transmission of HIV (PMTCT) programme has
evolved over the past decade and currently comprises of
HIV counselling, HIV-testing, infant feeding counselling,
and antiretroviral prophylaxis.
In Uganda, the burden of mother-to-child transmis-
sion of HIV in Uganda is high because of the large
number of deliveries (1.3 million deliveries per year),
almost universal breastfeeding [1] and the high [6.0%]
antenatal HIV prevalence [2,3]. This implies that about
78 000 of the women who deliver annually are living
with HIV. Hence without any interventions for PMTCT,
about 30% of these women would pass the virus to their
babies. This translates to about 23 400 infected children
every year, at least half of would be prevented if there
were a nation-wide PMTCT programme. The national
PMTCT programme was launched as a pilot interven-
tion in 8 hospitals in the year 2000, and was integrated
into existing antenatal care services. The Government of
Uganda in collaboration with UNAIDS, UNICEF and
other partners scaled up the PMTCT programme to all
districts by December 2004. The programme was intro-
duced as a client-initiated approach where antenatal
care clients were encouraged to undergo counselling
and testing for HIV if they so wished. This approach is
also known as ‘opt-in’ or voluntary counselling and test-
ing (VCT).
The prevention of mother-to-child transmission of
HIV package consisted of interventions designed to
reduce the risk of HIV transmission during pregnancy,
labour, delivery and during the postnatal period. The
comprehensive PMTCT package comprises of the fol-
lowing:
• VCT that is integrated within the antenatal clinic
services
• Quality antenatal, intra-natal and postnatal care
services as well as follow-up support for both the
mother and baby
• Antiretroviral (ARV) drugs for HIV-positive
mothers and their babies
• Counselling and support on optimal infant and
young child feeding
• Promotion of family and community support
including the involvement of male partners and
spouses
The ARV prophylaxis regimen was a single dose of
Nevirapine (NVP) 200 milligrams (mg) to the mother at
onset of labour, and a single of NVP (2 mg/kilogram
[kg] body weight), to the baby within 72 hours of birth.
The infant feeding options to HIV infected mothers
were either breastfeeding only for 3 months with abrupt
weaning or replacement feeding if it was affordable, fea-
sible, acceptable sustainable and safe (AFASS). By
December 2005, the PMTCT programme was providing
HIV counselling to about 35% and HIV testing to about
20% of all pregnant women in the country. Only 15% of
the pregnant women living with HIV in the country
were identified and about 10% of them accessed prophy-
lactic antiretroviral drugs for PMTCT [4]
Following CDC and UNAIDS/WHO recommenda-
tions [5,6], there was a change in strategy in the year
2006. The provider-initiated approach that routinely
tests all antenatal attendees for HIV was introduced in
the PMTCT programme in Uganda in 2006. This
approach is also known as ‘opt-out’ or routine counsel-
ling and testing (RCT). Concurrently, new guidelines on
the use of ARV prophylaxis for PMTCT were issued.
The ARV regimen included: Zidovudine (AZT, ZDV)
300 mg given to the mother orally plus Lamivudine
(3TC) 150 mg twice a day starting from 32 weeks
through out labour and boosted by a single dose of NVP
200 mg at onset of labour. Then she continues with
AZT plus 3TC twice a day for one week after delivery.
The baby receives a single dose of NVP syrup (2 mg/kg
body weight) within 72 hours of birth and AZT syrup (4
mg/kg body weight, twice a day for seven days. The
HIV-infected mothers were recommended to either
exclusively breastfeed for 6 months instead of 3 months
or give replacement feeds if affordable, feasible, accepta-
ble sustainable and safe.
In Uganda, about 94% of the women attend the
antenatal clinic at least once during pregnancy but less
than half (47%) of them receive 4 or more visits for
antenatal care. Only about 17% of the women make
their first antenatal visit in the first three months of
pregnancy. However, a high proportion (41%) of women
makes their first antenatal care (ANC) visit in the fourth
or fifth months of pregnancy. The median gestational
age at the first visit is 5.5 months, when the opportunity
may have passed to diagnose problems early, provide
treatment, and prevent further complications. About
41% of women deliver in a health facility and about 58%
deliver at home [7]. The aim of this paper is to describe
the experience of the past 7 years of the PMTCT pro-
gramme in Mbale Regional Hospital, Eastern Uganda,
with particular reference to the lessons learnt in chan-
ging from the VCT to the RCT strategy for HIV testing
and counselling in antenatal services.
Methods
The study was conducted at Mbale Regional Referral
Hospital in Mbale district, Eastern Uganda. It was a ret-
rospective analysis of data from hospital records on HIV
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counselling and testing of antenatal attendees in the
hospital covering a seven year period (May 2002 to
April 2009). The hospital is located in Mbale town
approximately 240 kilometres North-East of Kampala
city by road. The district had a population of over
720 000 in the year 2002, with an annual population
growth rate of 2.5%. Like the rest of Uganda, 92% of the
people live in the rural areas and are predominantly
Bagisu or Bamasaba. The main language is Lumasaba
and the main economic activity is subsistence farming.
The literacy rate was 64% for men and 49% for women
[8]. In 2003, the HIV prevalence was reported to be
5.6% [9]. The PMTCT services are offered at Mbale
Regional Referral Hospital, Bufumbo Health Centre IV
and some of health centre III units in the district. It is a
regional referral hospital for 11 districts in Eastern
Uganda and serves an estimated population of 1.9 mil-
lion people. The hospital has a bed capacity of 380 and
serves approximately 6 000-9 000 new antenatal atten-
dees per year. The antenatal care services are provided
daily except weekends. The average attendance is 50-60
pregnant women per day, including those who come for
ANC return visits. The HIV testing policy is communi-
cated to women attending ANC by either nurses/mid-
wives or lay counsellors during the health talk given in
the morning after the mothers’ registration exercise in
the clinic. All the health workers involved in the
PMTCT programme underwent a basic two-week
course on counselling for PMTCT and a one-week
course on infant and young child feeding counselling,
though some of them are now fully-trained professional
counsellors. They also received a one-week refresher
course on updates about HIV counselling and testing
before the introduction of RCT in June 2006. Initially
the counsellors offered one-to-one pre and post-test
counselling, since the number of clients accessing the
PMTCT services was low. However, as the number
of antenatal attendees undergoing VCT increased, pre-
testing counselling was given to small groups of about 5
clients (from January 2003) but individual post-test
counselling was maintained. The pregnant women were
encouraged to come for HIV testing with their partners
but very few men showed up for VCT. However since
introduction of RCT in June 2006, the service-providers
give pre-test group counselling to large groups of ANC
attendees, but offer one-to-one post-test counselling to
the women. Couples who come for RCT are seen first
before attending to the mothers who come alone as one
way of encouraging couple attendance.
HIV testing is done on-site by the health staff in the
antenatal clinic who have received a five-day training on
HIV tests using rapid HIV testing kits. All the other
routine antenatal tests are performed by the laboratory
staff in the hospital’s main laboratory nearby. A
sequential HIV testing algorithm, with same day results,
including three rapid tests is used on one blood sample:
Determine HIV 1/2 assay (Abbott Laboratories, Abbott
Park, IL, USA) for first screening; STAT-PAK HIV 1/2
DIPSTICK assay (Chembio Diagnostic Systems Inc.) as a
second test and Uni-Gold (Trinity Biotech, Wicklow,
Ireland) as a “tie-breaker”. The ANC attendees are clas-
sified as uninfected if Determine is negative and as HIV-
infected if both Determine and STAT-PAK tests are
positive. Discordant Determine and STAT-PAK blood
samples are tested using the Uni-Gold test. The HIV
test result is reported as positive if the Uni-Gold test is
positive or as negative if both STAT-PAK and Uni-Gold
tests are negative. Since 2006 ANC attendees who test
HIV-positive undergo CD4 cell count before being given
appropriate treatment according to the national PMTCT
guidelines [10].
Several registers are used to monitor and evaluate the
performance of the PMTCT programme. The VCT and
HIV Register is used during counselling and testing for
HIV to collect data from all women who are counselled.
The Enrolment Register is used to collect information
from HIV positive mothers at the time of getting the
antiretroviral drugs (accessed free of charge in the
antenatal clinic or the labour ward). The Delivery and
Birth Register is used to collect information from all
HIV-positive women who have been enrolled on the pro-
gramme, at the time when they are in labour and imme-
diately after they have delivered. The Follow-up Register
is used to collect data during the postnatal period and
beyond while the mother and baby are being followed up
till the bay is at least eighteen months of age. In addition,
there are two summary registers, namely the Antenatal
Summary Register and the Delivery Summary Register,
for monthly antenatal activities as well as activities
related to labour and delivery. Every month, the PMTCT
coordinator in the hospital compiles a report about the
PMTCT activities in the hospital, a copy of which is sent
to the National PMTCT programme manager in the
Ministry of Health headquarters.
We analysed the monthly PMTCT programme
reports, the VCT and HIV Registers, the Enrolment Reg-
isters and the Antenatal Summary Registers in the
antenatal clinic, and the Delivery Summary Registers
and HIV registers in the maternity ward at Mbale Regio-
nal Referral Hospital covering a seven-year period (May
2002-April 2009). The data was extracted using a stan-
dardized data extraction form, and entered into an excel
sheet. The variables of interest were: total number of
new antenatal attendees per year, number of ANC
attendees counselled about HIV, number of ANC atten-
dees who underwent HIV-testing and number of ANC
attendees who obtained a positive HIV-test result.
The other variables were: number of male partners
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counselled for HIV, number tested for HIV and number
of those who obtained a positive HIV-test result, num-
ber HIV-infected mothers and their infants who
received ARV prophylaxis for PMTCT. The total num-
ber of new attendees and male partners who accessed
the ANC and PMTCT services, and the total number of
HIV-positive women and their infants that accessed
ARV drugs (ARVs) was computed annually. The percen-
tages of the ANC attendees or their male partners who
were counselled and tested for HIV and of those who
tested HIV-positive were calculated. The few pregnant
women who knew that they were HIV positive at their
first antenatal visit were recorded in the VCT and HIV
Registers as having been counselled about HIV and
infant feeding options, and we included them in the
analysis among the total number HIV-positive ANC
attendees. The Student’s t-test was used to compare
some selected indicators for PMTCT in the hospital
before and after the policy change in antenatal HIV-
testing approach. A p-value of < 0.05 was considered
statistically significant.
Ethical clearance to conduct the study was obtained
from the Research and Ethics Committee of the School
of Medicine, Makerere University College of Health
Sciences; the Uganda National Council of Science and
Technology; and the National PMTCT programme,
Ministry of Health, Uganda. Permission to use the hos-
pital records was obtained from the Mbale Regional
Referral Hospital administration through the local insti-
tutional review board.
Results
Overall results of HIV testing
From May 2002 to April 2009, a total of 54 429 new
ANC attendees and 469 male-partners accessed antena-
tal services at Mbale Regional Referral Hospital. Of all
the new ANC attendees, 42 754 (78.6%) were counselled
about HIV, 28 108 (51.6%) were tested for HIV and
1713 (6.1%) of those tested received an HIV-positive
result. During the same period, a total of 469 male part-
ners received HIV counselling while 459 (97.9%) of
them were tested for HIV and 40 (8.7%) of those tested
were HIV positive.
Trends of HIV testing in pregnant women
From May 2002 to May 2006 (VCT period), 6 570
(22.0%) out of 29 834 new ANC attendees were tested
for HIV as compared to 21 538 (87.6%) out of 24 595
new ANC attendees who were tested during the RCT
period from June 2006 to April 2009 (p = 0.002), with a
corresponding increase in numbers of HIV-infected
women identified antenatally (n = 1147, 5.3% sero-
prevalence as compared with 566, 8.6% sero-prevalence
in the VCT period, p = 0.012), Figure 1 and table 1.
During the period of May 2002 to April 2003, a total
of 6 298 pregnant mothers attended their first antenatal
visits. Of these, 1 903 (30%) were counselled and 209
(3%) were tested for HIV. A steady increase in pregnant
mothers accepting voluntary counselling and testing
(VCT) for HIV was observed during the first three years
of the PMTCT programme, Figure 2 and table 2. From
May 2004 to April 2005, out of 7 982 new ANC atten-
dees, 3 546 (44%) accepted HIV testing. However in the
following year (May 2005 - April 2006), 1 915 (22.9%)
out of 8 358 pregnant mothers were tested for HIV
though 5 811 (73%) new ANC attendees had been
counselled.
In the first year after the policy change from VCT to
RCT, there was a dramatic increase in the number of
mothers who were tested for HIV. Out of 7 286 new
ANC attendees, 6 393 (79%) of them were tested for
HIV. The number of mothers accepting an HIV-test
rose to 95% (7 792 mothers out of 8 245) in the period
from May 2008 to April 2009, table 2. The increase in
coverage of antenatal HIV testing among the pregnant
women led to a corresponding significant increase in
the use of PMTCT interventions, table 1.
Trends of HIV testing in men
During the VCT period, out of 80 male partners that
accompanied their spouses to the antenatal clinic, 70
(87.5%) of them were tested for HIV compared with 389
male partners (100%) who escorted their spouses for
antenatal care and accepted HIV testing (p = 0.010),
with a corresponding increase in the numbers of HIV-
infected male partners identified in the RCT period (n =
25, 6.4% sero-prevalence as compared with 15, 21.4%
sero-prevalence in the VCT period, p = 0.103), table 1
and table 3. In comparison with the new ANC atten-
dees, the number of male partners who underwent
counselling and testing for HIV at the antenatal clinic in
Mbale Regional Referral Hospital remained very low
despite the change from VCT to RCT approach in HIV
testing, table 1 and 3.
Discussion
Our study showed that the policy change from VCT to
RCT dramatically increased the number of mothers
tested for HIV. This change was sustained over the
3 years of observation. These findings are similar to
those reported elsewhere in Africa [11]. In rural Malawi,
the number of pregnant women who accepted HIV-test-
ing increased from 78.7% to 98.8% after changing from
VCT to RCT testing approach for HIV[12]. A study
from an urban area in Zimbabwe found that 99.9% of
the ANC attendees underwent HIV-testing during the
first 6 months of routine HIV-testing compared to 65%
of the women during the last 6 months of opt-in testing
Byamugisha et al. BMC Health Services Research 2010, 10:290
http://www.biomedcentral.com/1472-6963/10/290
Page 4 of 8
Figure 1 Trends in HIV testing among new antenatal attendees, Mbale Regional Referral Hospital, 2002-2009.
Table 1 Selected indicators of prevention of mother-to-child HIV transmission at Mbale Regional Referral Hospital,
2002-2009
Indicator Voluntary HIV testing period
n (%)
Routine HIV testing period
n (%)
P-value (two-tailed)
New ANC attendees
Booked for ANC 29834 24595 -
Counselled for HIV 18583 (62.3) 24171 (98.3) 0.042*
Tested for HIV 6570 (22.0) 21538 (87.6) 0.002*
HIV positive 566 (8.6) 1147 (5.3) 0.012*
Male Partners of the ANC attendeesa
Counselled for HIV 80 (100) 389 (100) 0.012*
Tested for HIV 70 (87.5) 389 (100) 0.010*
HIV positive 15 (21.4) 25 (6.4) 0.112
HIV- infected pregnant women
Used ARVs for PMTCTb 316 (55.8) 885 (77.2) 0.015*
Delivered in hospital 172 (30.4) 464 (40.5) 0.042*
Infants given ARVs for PMTCTc 184 (32.5) 451 (39.3) 0.050
* Statistically significant p-value of the independent-samples t-test at the 0.05 level.
a All male partners who accompanied their spouses for the antenatal care visit were counselled about HIV.
b During the VCT period the HIV- infected women and their infants received single dose Nevirapine (sdNVP), but in the RCT period the mothers received a
combination regimen of Zidovudine (ZDV, AZT) and Lamivudine (3TC) from 32 weeks plus sdNVP at onset of labour. The infants received sdNVP syrup and ZDV
syrup for one week. Women were started on HAART after 14 weeks gestation if they had a CD4 count of < 350 or WHO disease stage 3 or 4 clinically.
c Some babies were brought to hospital for the ARVs within 72 hours of birth outside the hospital and some babies born in the hospital missed getting ARVs
when out of stock.
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[13]. A study conducted in Botswana demonstrated an
increase in HIV testing rate from 75% in the last 3
months of VCT period to 91% in the first 4 months of
RCT period [6].
The high proportion of routine HIV-testing in our
study could be attributed to several factors. The new
ANC attendees were less fearful of accepting HIV-
testing because the opt-out approach was perceived by
their partners and families as “standard of care” given to
all pregnant women in the antenatal clinic. In addition,
the availability of rapid HIV-testing in the clinic and the
giving of same-day HIV test results may have contribu-
ted to the high proportion of HIV-testing. The refresher
courses given to the ANC providers/counsellors with
the launch of RCT in June 2006 may have equipped
them with improved HIV counselling and testing skills,
and thus may have had a positive impact on the testing
during the RCT period. Our study has also shown that
the high coverage of antenatal HIV-testing after policy
change significantly identified more HIV-infected preg-
nant women who easily accessed the free antiretroviral
drugs (ARVs) in the antenatal clinic and the maternity
ward. A similar finding was reported in study in
Zimbabwe [13].
During the first 3 years of the VCT period (May 2002
- April 2005), there was a substantial increase in HIV
Figure 2 Trend of HIV counselling, testing and sero-positivity among new antenatal attendees, Mbale Regional Referral Hospital,
2002-2009.
Table 2 Antenatal HIV counselling and testing among new attendees at Mbale Regional Referral Hospital, 2002-2009
Period HIV testing Approach New ANC attendees
N
Counselled
n (%)
Tested
n (%)
HIV-positive
n (%)
May 02 - April 03 VCT 6 298 1 903 (30.2) 209 (3.3) 45 (21.5)
May 03 - April 04 VCT 6 468 4 407 (68.1) 900 (13.9) 101 (11.2)
May 04 - April 05 VCT 7 982 5 811 (72.8) 3 546 (44.4) 288 (8.1)
May 05 - April 06 VCT 8 358 6 462 (77.3) 1 915 (22.9) 132 (6.9)
May 06 - April 07 RCT 8 079 7 286 (90.2) 6 393 (79.1) 356 (5.6)
May 07 - April 08 RCT 8 999 8 851 (98.4) 7 353 (81.7) 387 (5.3)
May 08 - April 09 RCT 8 245 8 034 (97.4) 7 792 (94.5) 404 (5.2)
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testing among the antenatal attendees from 3.3% to 44%,
but testing coverage halved in the following year (May
2005/April 2006). This decline was largely due to inade-
quate supplies of HIV-test kits and sundries during that
period and the HIV-test tests were completely out of
stock in the months of April and May 2006, Figure 2.
During those two months about 1400 new attendees vis-
ited the antenatal clinic but could not be offered HIV-
testing services, leading to missed opportunities as has
been documented elsewhere [14-16].
The apparent higher prevalence of HIV in the VCT
period is likely to be attributed to selection bias. It is
probable that the ANC attendees who perceived them-
selves to be at higher risk of HIV infection were the
ones that most likely opted to test for HIV voluntarily.
Coupled with the small number of pregnant women
that were tested for HIV, this may partly explain the
higher prevalence of HIV during the VCT period. The
shift from one-to-one pre-test counselling to group pre-
test counselling seems not to have impacted on the test-
ing rates since there was a substantial increase in
antenatal HIV-testing rates from 14% to 44% in the per-
iods May 2003/April 2004 and May 2004/April 2005
respectively.
Our study showed that the number of male partners
who tested for HIV at the antenatal clinic was low
(below 5%) compared to the total number of the ANC
attendees despite the change from “opt-in” to “opt-out”
approach in HIV-testing. Poor male partner involvement
in PMTCT programme has been documented elsewhere
in Africa, and studies in Tanzania, Kenya and Zambia
[17,7] have reported HIV testing rates among male part-
ners of 9% to 16%. Male partner involvement is essential
for improving PMTCT outcomes [17-19]. Thus the low
rate of HIV-testing among the male partners remains a
major challenge to the PMTCT programme in Uganda.
Overall, 98% of the male partners of the new ANC
attendees were tested for HIV. During the “opt-in” per-
iod, 88% of the male partners accepted HIV testing
while 100% accepted HIV testing in the “opt-out”
period. Although the number of male partners in our
study was small, the opt-out approach appears to
increase male partner testing for HIV.
The study revealed that the average prevalence of HIV
among the new ANC attendees over the 7-year study
period was 6.1%. Similarly, HIV prevalence rates of 6.0%
and 5.9% have been reported by Musinguzi et al and
the Uganda Demographic and Health Survey respec-
tively [2,3]
Our study had a number of limitations. It was a retro-
spective analysis of routinely collected data in the
antenatal clinic and made comparisons between two dif-
ferent time periods. Accordingly, the study may have
suffered from selection bias arising from differential
selection of the participants, and from confounding due
to inability to measure and control for potential con-
founders concurrently. For example, it was not possible
to measure and control for other possible factors like
media influence that may have contributed to the
increase in HIV testing that was observed in the study.
The change in HIV testing from VCT to RCT coincided
with a period of wide availability of free ARVs especially
for treatment. This may have been a potential confoun-
der since the ANC attendees knew they could easily
access the required ARVs in case they were found to be
HIV positive. It is also possible that the policy change in
HIV testing strategy may have introduced some mea-
surement bias but this is likely to have been minimal. In
addition, there was missing data and limited demo-
graphic data in the records that may also have impacted
on the study findings. Finally, the small number of male
partners who accessed the PMTCT services may also
have affected the validity of the data on male partners in
the study.
Conclusions
Despite these limitations, our study documented a dra-
matic and sustained increase in antenatal HIV testing
among pregnant women and their partners in Mbale,
Eastern Uganda following the change from VCT to
Table 3 Male partners counselled and tested for HIV at Mbale Regional Referral Hospital, 2002-2009
Period HIV testing approach Male partnersa counselled
N
Male partners tested
n (%)
Male partners HIV-positive
n (%)
May 02 - April 03 VCT 8 7 (87.5) 3 (42.9)
May 03 - April 04 VCT 6 6 (100) 1 (16.7)
May 04 - April 05 VCT 32 28 (87.5) 8 (28.6)
May 05 - April 06 VCT 34 29 (85.3) 3 (10.3)
May 06 - April 07 RCT 103 103 (100) 11 (10.7)
May 07 - April 08 RCT 92 92 (100) 9 (9.8)
May 08 - April 09 RCT 194 194 (100) 5 (2.6)
a All male partners who accompanied their spouses for antenatal care were counselled (100%) and most of them were tested for HIV in the antenatal clinic.
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RCT. Our findings call for further strengthening of the
policy for routine HIV testing in antenatal clinics. Our
study also showed that male partner HIV testing in
antenatal clinics is low and this area needs further work
through research and innovative interventions in order
to improve male partner involvement.
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